A Study of E7070 in Patients With Gastric Cancer
NCT00165594
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was completed.
Conditions
Gastric Cancer
Interventions
DRUG:
E7070
Sponsor
Eisai Co., Ltd.